Integra Lifesciences Q4 Adjusted EPS $0.89 Misses $0.90 Estimate, Sales $397.04M Miss $399.34M Estimate
Author: Benzinga Newsdesk | February 28, 2024 07:03am
Integra Lifesciences (NASDAQ:
IART) reported quarterly earnings of $0.89 per share which missed the analyst consensus estimate of $0.90 by 1.11 percent. This is a 5.32 percent decrease over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $397.04 million which missed the analyst consensus estimate of $399.34 million by 0.58 percent. This is a 0.25 percent decrease over sales of $398.02 million the same period last year.
Posted In: IART